ISALT, through its Fonds Stratégique des Transitions, announces a new investment in DentalMonitoring

Paris, February 10, 2026

The Fonds Stratégique des Transitions (FST) has completed its 9th investment in DentalMonitoring, the global pioneer in orthodontic remote monitoring.

DentalMonitoring has closed a growth funding round of approximately €85 million, with the FST and Lazard Elaia Capital as investors. The company, recognized for its innovative technology protected by over 470 patents and its proprietary AI trained on millions of clinical images, has obtained FDA De Novo certification.

A partnership to accelerate innovation in dental healthcare
This investment, the FST’s ninth operation, will enable DentalMonitoring to:
– Strengthen its international expansion, consolidating its position in existing markets and exploring new regions;
– Extend its applications to other dental health segments;
– Reinforce its technological leadership, delivering increasingly high-performance solutions for patients and practitioners.

A vision aligned with the FST’s core mission
Through this investment, ISALT reaffirms its commitment to supporting innovative companies in their industrial scaling, while addressing the challenges of technological and societal transitions.